# FDA Inspection 1264387 - Grainger - March 05, 2025

Source: https://www.keypedia.com/records/fda_inspections/grainger/6c1338b1-38f6-47d3-9125-49d02f24b1d4
Source feed: FDA_Inspections

> FDA Inspection 1264387 for Grainger on March 05, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264387
- Company Name: Grainger
- Inspection Date: 2025-03-05
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1209662 - 2023-06-16](https://www.keypedia.com/records/fda_inspections/grainger/89bdeb34-d6d9-4bf8-90cc-848116c93993)

Company: https://www.keypedia.com/companies/grainger/6bcb1fd7-96f0-4dd2-873c-f42d6c4b31ee

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
